Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A nucleic acid inhibitor is a type of antimicrobial agent that acts by inhibiting the synthesis or function of nucleic acids (DNA or RNA) within target organisms. These agents exploit differences between prokaryotic and eukaryotic enzymes involved in nucleic acid metabolism to achieve selective toxicity against pathogens. Classes include DNA inhibitors (e.g., quinolones targeting DNA gyrase), RNA inhibitors (e.g., rifampin targeting RNA polymerase), and antifolates (e.g., trimethoprim-sulfamethoxazole) which indirectly inhibit both DNA and RNA production. Emerging applications include nucleic acid-based therapeutics and small molecules targeting specific RNAs.
Inhibition of DNA gyrase/topoisomerase, RNA polymerase, or nucleotide biosynthesis pathways.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleic Acid Inhibitor.